REGN logo

REGNRegeneron Pharmaceuticals, Inc.

$639.47
$20.52
(3.32%)
Pre-Market
Updated: 05:50 AM EDT·Prev Close $618.95
EarningsJul 30
Mkt Cap$63.21B
Vol984.00
Upcoming Earnings: Q2 '26

Reports: Jul 30Pre-Market

Estimated EPS

$10.85

Estimated Rev

$3.82B

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
$10.85
--
--
N/A
Q1 '26
$8.91
$9.47
6.24%
BEAT
Q4 '25
$10.74
$11.44
6.56%
BEAT
Q3 '25
$9.65
$11.83
22.53%
BEAT
Q2 '25
$8.43
$12.89
52.89%
BEAT